Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Gender-affirming treatment of transgender people requires a multidisciplinary approach in
which endocrinologists play a crucial role. The aim of this paper is to review recent data on …

Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

Importance Transgender and gender-diverse individuals face unique challenges, including
barriers to health care access and inequities in treatment, that may influence cancer risk and …

Background Transgender individuals receive cross-sex hormonal therapy to induce desired
secondary sexual characteristics despite limited data regarding its effects on cardiovascular …

Many transgender men and women seek hormone therapy as part of the transition process.
Exogenous testosterone is used in transgender men to induce virilization and suppress …

Gender-affirming or cross-sex hormone therapy is integral to the management of
transgender individuals yet our appreciation of the effects of such hormones on …

Objective Hormone therapy in transgender people might be associated with an increased
risk of cardiovascular disease (CVD). We aimed to investigate whether the risk of CVD is …

Testosterone therapy is a cornerstone of medical treatment for transgender men who choose
to undergo it. The goal of testosterone therapy is usually to achieve serum testosterone …

I review the current status of transgender people's access to health care in the United States
and analyze federal policies regarding health care services for transgender people and the …